Literature DB >> 25275130

HIV-1 envelope glycan moieties modulate HIV-1 transmission.

Ruizhong Shen1, Milan Raska2, Diane Bimczok3, Jan Novak4, Phillip D Smith5.   

Abstract

UNLABELLED: The HIV-1 envelope protein (Env) is heavily glycosylated, with approximately 50% of the Env molecular mass being contributed by N-glycans. HIV-1 Env N-glycans shield the protein backbone and have been shown to play key roles in determining Env structure, surface exposure, and, consequently, antigenicity, infectivity, antibody neutralization, and carbohydrate and receptor binding. Studies of HIV-1 glycosylation have focused mainly on the position of glycosylation, rather than the types of glycans. Also, the role of Env glycan moieties on HIV-1 transmission has not been systematically defined. Using viruses with modified Env glycan content and heterogeneity, we examined the effects of Env glycan moieties on the major events of HIV-1 transmission. Compared to viruses with less oligomannose and more complex Env glycans, viruses with more oligomannose and less complex glycans more efficiently (i) transcytosed across an epithelial cell monolayer, (ii) attached to monocyte-derived macrophages (MDMs), (iii) bound monocyte-derived dendritic cells (MoDCs), and (iv) trans-infected primary lymphocytes via MoDCs. However, viruses with more oligomannose and less complex glycans displayed impaired infectivity in TZMbl cells, MDMs, primary lymphocytes, and fresh human intestinal tissue. Thus, N-linked Env glycans display discordant effects on the major events of HIV-1 transmission, with mature oligosaccharide structures on Env playing a crucial role in HIV-1 infection. Env glycosylation should be taken into consideration in the development of vaccine strategies to interdict HIV-1 transmission. IMPORTANCE: HIV-1 Env N-glycans shield the protein backbone and play key roles in determining Env structure and surface exposure, thereby impacting Env antigenicity, infectivity, antibody neutralization, and carbohydrate and receptor binding. Studies of HIV-1 glycosylation have focused mainly on the position of glycosylation, rather than the types of glycans. In the study described in this report, we investigated systematically the role of Env glycan moieties on HIV-1 transmission. We show that N-linked Env glycans display discordant effects on the major events of HIV-1 transmission. These data indicate that Env glycan moieties impact HIV-1 transmission and that modulation of Env glycan moieties offers a potential strategy for the development of therapeutic or prophylactic vaccines against HIV-1.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25275130      PMCID: PMC4249159          DOI: 10.1128/JVI.02164-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

Authors:  T B Geijtenbeek; D S Kwon; R Torensma; S J van Vliet; G C van Duijnhoven; J Middel; I L Cornelissen; H S Nottet; V N KewalRamani; D R Littman; C G Figdor; Y van Kooyk
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

2.  DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection.

Authors:  Douglas S Kwon; Glenn Gregorio; Natacha Bitton; Wayne A Hendrickson; Dan R Littman
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

3.  Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.

Authors:  H Feinberg; D A Mitchell; K Drickamer; W I Weis
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

4.  A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency.

Authors:  G J Gerwig; E Bause; L K Nuytinck; J F Vliegenthart; W Breuer; J P Kamerling; M F Espeel; J J Martin; N W Chan; G A Dacremont
Journal:  Am J Hum Genet       Date:  2000-04-28       Impact factor: 11.025

5.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors.

Authors:  S E Malenbaum; D Yang; L Cavacini; M Posner; J Robinson; C Cheng-Mayer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 7.  Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.

Authors:  M Moulard; E Decroly
Journal:  Biochim Biophys Acta       Date:  2000-11-10

8.  Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.

Authors:  Miriam I Quiñones-Kochs; Linda Buonocore; John K Rose
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Processing of N-linked carbohydrate chains in a patient with glucosidase I deficiency (CDG type IIb).

Authors:  Christof Völker; Claudine M De Praeter; Birgit Hardt; Willi Breuer; Burga Kalz-Füller; Rudy N Van Coster; Ernst Bause
Journal:  Glycobiology       Date:  2002-08       Impact factor: 4.313

10.  A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization.

Authors:  Wenbo Wang; Jianhui Nie; Courtney Prochnow; Carolyn Truong; Zheng Jia; Suting Wang; Xiaojiang S Chen; Youchun Wang
Journal:  Retrovirology       Date:  2013-02-06       Impact factor: 4.602

View more
  12 in total

1.  Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function.

Authors:  Bin Wang; Yujie Wang; Dylan A Frabutt; Xihe Zhang; Xiaoyu Yao; Dan Hu; Zhuo Zhang; Chaonan Liu; Shimin Zheng; Shi-Hua Xiang; Yong-Hui Zheng
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

2.  Mother-to-Child HIV-1 Transmission Events Are Differentially Impacted by Breast Milk and Its Components from HIV-1-Infected Women.

Authors:  Ruizhong Shen; Jenna Achenbach; Yue Shen; Jana Palaia; Jeremy T Rahkola; Heidi J Nick; Lesley E Smythies; Michelle McConnell; Mary G Fowler; Phillip D Smith; Edward N Janoff
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

3.  Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glycans Is Not Compatible with Mucosal Transmission in Rhesus Macaques.

Authors:  Christina B Karsten; Falk F R Buettner; Samanta Cajic; Inga Nehlmeier; Berit Neumann; Antonina Klippert; Ulrike Sauermann; Udo Reichl; Rita Gerardy-Schahn; Erdmann Rapp; Christiane Stahl-Hennig; Stefan Pöhlmann
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

4.  HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.

Authors:  Karen P Coss; Snezana Vasiljevic; Laura K Pritchard; Stefanie A Krumm; Molly Glaze; Sharon Madzorera; Penny L Moore; Max Crispin; Katie J Doores
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

5.  Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120.

Authors:  Jason Yolitz; Catherine Schwing; Julia Chang; Donald Van Ryk; Fatima Nawaz; Danlan Wei; Claudia Cicala; James Arthos; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

6.  HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses.

Authors:  Evelyn Ngwa Lumngwena; Simon Metenou; Lindi Masson; Claudia Cicala; James Arthos; Zenda Woodman
Journal:  Retrovirology       Date:  2020-07-02       Impact factor: 4.602

7.  HIV-1 Envelope Glycan Composition as a Key Determinant of Efficient Virus Transmission via DC-SIGN and Resistance to Inhibitory Lectins.

Authors:  Muzafar Jan; Chitra Upadhyay; Catarina E Hioe
Journal:  iScience       Date:  2019-10-18

8.  Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.

Authors:  Ousman Jobe; Hung V Trinh; Jiae Kim; Wadad Alsalmi; Sodsai Tovanabutra; Philip K Ehrenberg; Kristina K Peachman; Guofen Gao; Rasmi Thomas; Jerome H Kim; Nelson L Michael; Carl R Alving; Venigalla B Rao; Mangala Rao
Journal:  J Leukoc Biol       Date:  2015-12-14       Impact factor: 4.962

9.  Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies.

Authors:  Qing Wei; Audra A Hargett; Barbora Knoppova; Alexandra Duverger; Reda Rawi; Chen-Hsiang Shen; S Katie Farney; Stacy Hall; Rhubell Brown; Brandon F Keele; Sonya L Heath; Michael S Saag; Olaf Kutsch; Gwo-Yu Chuang; Peter D Kwong; Zina Moldoveanu; Milan Raska; Matthew B Renfrow; Jan Novak
Journal:  iScience       Date:  2020-10-21

Review 10.  Utilization of Galectins by Pathogens for Infection.

Authors:  Diyoly Ayona; Pierre-Edouard Fournier; Bernard Henrissat; Benoit Desnues
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.